Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era-Reference-Cited by-同舟云学术

Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era

Published:2021-12 Issue:4 Volume:14 Page:318-326
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Hong Sanghee,Rybicki Lisa,Corrigan Donna,Hamilton Betty K.,Sobecks Ronald,Kalaycio Matt,Gerds Aaron T.,Dean Rob M.,Hill Brian T.,Pohlman Brad,Jagadeesh Deepa,Anwer Faiz,Majhail Navneet S.

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference20 articles.

1. Epidemiology and biology of relapse after stem cell transplantation;Horowitz;Bone Marrow Transplant,2018

2. Current uses and outcomes of hematopoietic cell transplantation (HCT);D'Souza;CIBMTR Summary Slides,2019

3. Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation

4. Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia;Ossenkoppele;Haematologica,2016

5. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem‐cell transplantations: A single‐center experience;Clinical Transplantation;2024-05

2. Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report;Frontiers in Immunology;2023-09-28

3. Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015);Pediatric Drugs;2023-09-11

4. Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy;Cancers;2023-08-15

5. Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma;Cancers;2023-08-11